Not content with taking on the respiratory syncytial virus (RSV) prevention market with its antibody-based therapy Beyfortus, AstraZeneca has agreed to buy US biotech Icosavax and its phase 3 ...
Copyright: © 2025 The Author(s). Published by Elsevier Ltd. hMPV is now included as a routine target in diagnostic respiratory virus PCR kits that target RSV and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback